This inventor holds 2 USPTO granted patents. Top assignee: University of Medicine and Dentistry of New Jersey. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Edison, NJ (US) (1997)
- Gloucester, MA (US) (1997)
Company Filing History:
Years Active: 1997
Title: The Innovative Contributions of Natalie Sutkowski
Introduction
Natalie Sutkowski is a prominent inventor based in Edison, NJ (US). She has made significant contributions to the field of gene transfer technology, particularly in the context of primary lymphocytes. With a total of 2 patents, her work has the potential to advance medical research and therapeutic applications.
Latest Patents
One of her latest patents focuses on a method for efficiently introducing exogenous genes into primary lymphoid cells without the need for drug selection. This innovative approach involves several key steps, including deriving a retroviral vector and a helper cell combination that yields a high level of virus production. The process also includes isolating a lymphoid cell subpopulation, culturing it with specific growth factors, and co-cultivating it with a virus-producing cell line. The end result is a population of transfected lymphocytes, with over 90% containing a provirus.
Career Highlights
Natalie Sutkowski is affiliated with the University of Medicine and Dentistry of New Jersey, where she continues to push the boundaries of research in her field. Her work is characterized by a commitment to innovation and a focus on practical applications that can benefit the medical community.
Collaborations
Throughout her career, Natalie has collaborated with notable colleagues, including Joseph P Dougherty and Yacov Ron. These partnerships have further enriched her research and contributed to the advancement of gene transfer technologies.
Conclusion
Natalie Sutkowski's contributions to the field of gene transfer are noteworthy and reflect her dedication to innovation. Her patents and research have the potential to significantly impact medical science and therapeutic practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
